WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price dropped 0.3% during trading on Tuesday . The company traded as low as $20.20 and last traded at $20.20. 59 shares changed hands during trading, a decline of 94% from the average session volume of 924 shares. The stock had previously closed at $20.27.
WisdomTree BioRevolution Fund Stock Performance
The stock has a market cap of $2.97 million, a P/E ratio of 17.03 and a beta of 1.01. The business has a 50 day simple moving average of $18.83 and a 200-day simple moving average of $18.13.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC increased its stake in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,864 shares of the company’s stock after buying an additional 5,306 shares during the period. Jane Street Group LLC owned about 11.24% of WisdomTree BioRevolution Fund worth $231,000 as of its most recent SEC filing.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
See Also
- Five stocks we like better than WisdomTree BioRevolution Fund
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
